Page last updated: 2024-10-21

vanilmandelic acid and Adrenal Cortex Cancer

vanilmandelic acid has been researched along with Adrenal Cortex Cancer in 3 studies

Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.

Research Excerpts

ExcerptRelevanceReference
"Pheochromocytoma is mainly characterized by a great deal of variability in its biological activity and in its clinical manifestations."2.39[Diagnostic problems in pheochromocytoma]. ( Bellini, F; Ianni, L; Lanzillotti, R; Mannelli, M; Pupilli, C, 1995)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berbarie, RF1
Emmett, M1
Breslau, NA1
Mannelli, M1
Pupilli, C1
Lanzillotti, R1
Ianni, L1
Bellini, F1
Peñuela Melero, S1
Sancho Bueso, T1
Martínez Muñoz, I1
Riestra Martínez, ML1
García Puig, J1

Reviews

1 review available for vanilmandelic acid and Adrenal Cortex Cancer

ArticleYear
[Diagnostic problems in pheochromocytoma].
    Minerva endocrinologica, 1995, Volume: 20, Issue:1

    Topics: 3-Iodobenzylguanidine; Adrenal Cortex Neoplasms; Algorithms; Biomarkers; Catecholamines; Clonidine;

1995

Other Studies

2 other studies available for vanilmandelic acid and Adrenal Cortex Cancer

ArticleYear
Quiz page. Secondary hypertension with contralateral pheochromocytoma and aldosteronoma.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 46, Issue:1

    Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Antihypertensive Agent

2005
[Woman with refractory hypertension and hypokalemia].
    Revista clinica espanola, 1999, Volume: 199, Issue:6

    Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Adrenocorticotrop

1999